Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces its financial calendar for 2016:

• February 26, 2016                               Full-year 2015 results 
• April 6, 2016                                         General shareholders’ meeting (to be convened in Paris)
• April 28, 2016                                      Quarterly information as of March 31, 2016
• July 28, 2016                                        Consolidated accounts for the 1^st half of 2016
• October 25, 2016                                 Quarterly information as of September 30, 2016

 This financial calendar is for indicative purposes only and Onxeo could change its publication dates should it deem it necessary.

151215EN_Financial-Calendar-2016